Table 3 Risks of all-cause death associated with hypoalbuminemia combined with cardiometabolic diseases
Adverse outcome | Normoalbuminemia | Hypoalbuminemia combined with cardiometabolic diseases | Â | ||
|---|---|---|---|---|---|
0 | 1 |  ≥ 2 | P for trend | ||
Mortality | 418 (50.5%) | 32 (59.4%) | 62 (59.0%) | 10 (66.7%) | 0.152 |
HR (95% CI) | |||||
 Model 1 | 1 | 1.44 (1.01–2.06) | 1.34 (1.03–1.75) | 1.86 (0.99–3.48) | 0.002 |
 Model 2 | 1 | 1.44 (1.00–2.08) | 1.34 (1.02–1.75) | 1.97 (1.04–3.71) | 0.002 |
 Model 3 | 1 | 1.48 (1.02–2.13) | 1.39 (1.06–1.81) | 2.09 (1.11–3.93) | 0.001 |
 Model 4 | 1 | 1.54 (1.05–2.25) | 1.45 (1.08–1.93) | 2.15 (1.14–4.07) | 0.001 |